Delivery Order SPE2DB22D2206-SPE2DB26FDV11
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TECVAYLI 153 mg/1.7 ml vials valued at $11,868.12 on July 29, 2025, with a completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. TECVAYLI is a specialty pharmaceutical product reflecting the Defense Logistics Agency's ongoing procurement of specialized...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Tecvayli 153 mg/1.7 mL vials. This firm fixed price delivery order, valued at $11,868.12, represents a competitively awarded non-set-aside procurement with an ultimate completion date of September 18, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This delivery order, awarded on August 20, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of TECVAYLI 153 mg/1.7 mL vials for delivery to the contractor's facility in Conshohocken, Pennsylvania. The contract has a ceiling value of $11,868.12 under firm fixed-price terms, with an ultimate completion date of September 11, 2025. This is a non-set-aside award, reflecting open competition in the procurement process. The delivery order is issued as a...
- The Defense Logistics Agency awarded a $23.7K delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TECVAYLI 153 MG/1.7 ML vials. This firm fixed-price, non-set-aside contract is scheduled for completion by September 25, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply requirements through the agency's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tecvayli 153 mg/1.7 mL vials, a pharmaceutical product, with a ceiling value of $17,802.18. This firm fixed price delivery order, awarded on June 3, 2025, with an ultimate completion date of June 25, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $23,736.24 contract is for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 7, 2025. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,736.24, is for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a specialty medication. The contract has an ultimate completion date of March 17, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation indicated for this award. Amerisourcebergen holds a...
- The Defense Logistics Agency awarded a $27,926.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for TALVEY 40 mg/mL vials, with an ultimate completion date of September 2, 2025. This non-set-aside competitive award, issued on August 11, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 13, 2025, for the supply of Talvey 40 mg/ml vials valued at $27,926.36. This firm fixed price delivery order, with an ultimate completion date of September 4, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain and does not utilize a set-aside designation. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $13,963.18 delivery order to AmerisourceBergen Drug Corp for Talvey 40 mg/ml vials under a firm fixed price contract type. This delivery order, with an ultimate completion date of June 27, 2025, represents a child contract issued against the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDV11Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,802.15 for TECVAYLI 153 mg/1.7 ml vials on October 29, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TECVAYLI is a prescription pharmaceutical product, reflecting the agency's ongoing need to procure brand-name medications to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support mechanism, enabling the contractor to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a major pharmaceutical distributor serving critical federal medical procurement needs through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 10/29/25 |